In a new study, researchers analyze the world’s largest social media platform and its efforts to remove Covid-19 vaccine misinformation during the pandemic.
A social media campaign launched in 2022 helped encourage some Nigerians to roll up their sleeves for a COVID vaccine, according to a study published today in PLOS ONE.
The outbreak of the COVID pandemic in 2020 has once again shown how important reliable and rapid detection methods are to initiate effective measures to combat a pandemic.
As a result of vaccination or infection, our immune system produces antibodies that attach to the spike protein of SARS-CoV-2, preventing the virus from entering and replicating within cells.
People who bought firearms during the height of the COVID-19 pandemic have much higher rates of recent suicidal thoughts, self-harm behaviors, and intimate partner violence, a new study suggests, compared with other firearm owners and people who do not own firearms.
A late summer increase in COVID-19-related hospitalizations and the emergence of new coronavirus variants raises concerns about how best to counter infection and who should receive the newly-approved vaccines.
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking the antidepressant fluvoxamine at a dosage of 100 mg twice daily for 13 days for the treatment of mild-to-moderate COVID-19 symptoms.
Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”
The risk of developing long COVID is significantly lower following an infection with the Omicron variant than after an infection with earlier coronavirus variants. This was the finding of a study by University Medicine Halle, which was published in the “International Journal of Infectious Diseases”.
New UC Riverside research has revealed COVID’s Achilles heel — its dependence on key human proteins for its replication — which can be used to prevent the virus from making people sick.
High performance computing resources, advanced epidemiological models, and powerful algorithms will make dealing with future crises much easier, thanks to research led by Argonne National Laboratory.
It still feels like summer outside, but it’s time to prepare for the 2023-24 flu season.
$13 million will fund a multidisciplinary, multi-institution team effort to develop stronger and more versatile vaccines
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment, or BRaVE, initiative. BRaVE, announced earlier this year, aims to build on biopreparedness research that delivered high-impact results in the fight against COVID-19.
Type 1 diabetes is an autoimmune disease leading to an impaired glucose metabolism and requires life-long administration of insulin. While the cause of the autoimmunity reaction is still unclear, viral infections in young children are proposed to be critical environmental factors leading to type 1 diabetes.
A new editorial paper was published in Oncoscience (Volume 10) on September 1, 2023, entitled, “Exiting the pandemic together: achieving global immunity and equity.”
Researchers with the Department of Energy’s SLAC National Accelerator Laboratory and other institutions have been awarded $12 million in funding to help accelerate society’s response to emerging pathogens by improving X-ray science technology and processes.
Older adults who have had cancer had a high risk of experiencing symptoms of depression during the early months of the COVID-19 pandemic according to a new study published in Cancer Management and Research.
El Paso's journey began in March 2020 with its first confirmed case of COVID-19. By fall 2020, the city became the nation’s hotspot.
Throughout the COVID-19 pandemic, more than 3,200 Cedars-Sinai Medical Center nurses put on their protective gear and kept on going—providing the highest-quality patient care, conducting innovative research and creating new ways for patients to conveniently access Cedars-Sinai experts.
By now, most people have used an at-home test to find out if they have COVID-19. Rapid antigen tests are a fast and convenient way for people to test themselves for SARS-CoV-2, the virus that causes COVID-19. They’re a popular alternative to the polymerase chain reaction (PCR) tests that require a laboratory to process the results.
In a groundbreaking study conducted by Florida State University, wearable technology has emerged as a potential game-changer in the early detection of COVID-19 among NCAA Division I female student-athletes.
إن تلقي لقاح كوفيد-19 قد لا يُقلِّل فقط من خطر إصابة الشخص بكوفيد طويل الأمد، ولكنه قد يعني أيضًا أعراضًا أقل للأشخاص الذين يُصابون بهذه الحالة.
With an uptick in COVID cases and cold and flu season approaching, health experts are warning of a possible "tripledemic". Experts from Indiana University are able to comment.
Tomar a vacina contra COVID-19 pode não só reduzir os riscos de uma pessoa contrair COVID de longa duração, mas também pode significar a redução dos sintomas para a pessoa que desenvolver a doença.
Recibir la vacuna contra la COVID-19 podría significar no solo un menor riesgo de tener síndrome crónico de COVID, sino también la presencia de menos síntomas para quienes contraigan la afección.
Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.
Grandparents appeared to serve as an important private safety net when COVID-19 first hit the U.S., according to a study led by a Washington State University researcher.
Emergency medical technicians, firefighters, and other first responders are often hailed as heroes. But many of them experience the public’s elevated perceptions of them as a form of dehumanization, which can lead to burnout, according to a new study.
A new survey from the Association for Diagnostics & Laboratory Medicine (formerly AACC) found that clinical labs’ robust, rapid response to the COVID-19 pandemic helped to contain the virus and save lives. However, the challenges labs faced with insufficient supplies and staffing shortages have only intensified since 2020. The percentage of laboratory professionals reporting staffing issues rose steadily from 35.4% in May 2020 to 87.5% in January 2022—raising questions about whether labs would have the necessary resources to respond to a similar public health emergency today.
A DNA-based vaccine is very effective at protecting against COVID-19, according to a joint preclinical study by Scancell Ltd and Texas Biomedical Research Institute (Texas Biomed) recently published in the Journal of Biotechnology and Biomedicine.
Saad B. Omer, M.B.B.S., M.P.H., Ph.D., Founding Dean of the Peter O’Donnell Jr. School of Public Health at UT Southwestern Medical Center, discovered a passion for public health while he was a medical student in Pakistan.
White-tailed deer across Ohio have been infected with the virus that causes COVID-19, new research has found – and the results also show that viral variants evolve about three times faster in deer than in humans.
Bacteria in the mouth mostly survived infection — and that’s a good thing, says a Rutgers researcher.
Findings show how storytelling narratives of individuals’ experiences often leave out broader public health, socioeconomic and environmental contexts, which can be crucial for building empathy and influencing policy decisions.
SCALE-UP Counts was designed to promote COVID-19 testing in local schools. Huntsman Cancer Insitute’s Yelena Wu, PhD, hopes the insight gained from the program improves cancer screening and education initiatives.
Voluntary collective isolation alone was ineffective to mitigate the spread of COVID-19 into small-scale, remote Indigenous communities of the Tsimané in the Bolivian Amazon.
Keck Medicine of USC experts discuss new recommendations for staying healthy and safe during the respiratory virus season
Millions of Americans were exposed to SARS-CoV-2, the virus that causes COVID-19, early in the pandemic but could not get diagnosed due to testing limitations. Many of those people developed a post-viral syndrome with symptoms similar to those of long COVID.
High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study.
Bus drivers were at double the risk of being hospitalized for severe COVID-19 in the later stages of the pandemic, and several occupations in education and healthcare were also at risk of serious illness.
Getting a COVID-19 vaccine may not only reduce a person's risk of getting long-haul COVID, but also could mean fewer symptoms for people who develop the condition.
New research has identified which people with compromised immune systems are less likely to have COVID-19 antibodies - making them more vulnerable to a severe infection.
While COVID-19 lockdowns are no longer mandated, the stress and anxiety of the pandemic still lingers, especially among young South Australians, say health experts at the University of South Australia.
Severe COVID-19 may cause long-lasting alterations to the innate immune system, the first line of defense against pathogens, according to a small study funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
A Murdoch Children’s Research Institute-led review has found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
